StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Rexall

<< Previous

Bullboard Posts

Next >>

Comment by StevenBirchon May 11, 2021 9:43am

134 Views

Post# 33172682

RE:RE:Rexall

Or $0.72 anyway. Look I want it to go up as much as the next guy but this is not a covid stock. Covid testing while important is not the future and not where the money is even though it may add some revenue now. This stock is not at this level because we didn't get the Rexall announcement a month ago, it got halved because of an incoherent Aristotle message.

Some are trying to remain positive but others are either close to or outright pumpers. I say check the ones who attack anyone who even questions the near term outlook for this stock because the market seems to be backing those people right now.